iodixanol has been researched along with acetylcysteine in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 12 (70.59) | 29.6817 |
| 2010's | 5 (29.41) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Amhad, M; Boccalandro, F; Sdringola, S; Smalling, RW | 1 |
| Dean, LS | 1 |
| Baker, CS; Baker, LR; De Palma, R; Knight, CJ; Kumar, S; Wragg, A | 1 |
| Airoldi, F; Briguori, C; Carlino, M; Colombo, A; Condorelli, G; Focaccio, A; Montorfano, M; Morici, N; Ricciardelli, B; Sangiorgi, GM; Violante, A | 1 |
| Airoldi, F; Bonizzoni, E; Briguori, C; Carlino, M; Colombo, A; Cosgrave, J; D'Andrea, D; Focaccio, A; Michev, I; Montorfano, M; Morici, N; Ricciardelli, B | 1 |
| Coca, SG; Perazella, MA | 1 |
| Locatelli, F | 1 |
| Bashir, I; DeLago, A; El-Hajjar, M; Khan, M; Min, J; Torosoff, M | 1 |
| Fernandes, C; French, JK; Hallani, H; Jepson, N; Juergens, CP; Leung, DY; Lo, S; Nguyen-Do, P; Winter, JP | 1 |
| Aublet-Cuvelier, B; Cellarier, E; Decalf, V; Deteix, P; Heng, AE; Marcaggi, X; Motreff, P; Souweine, B | 1 |
| Coppola, JT; Doucet, S; Katholi, RE; Mody, KR; Sharma, SK; Solomon, R; Staniloae, CS | 1 |
| Angioli, P; Bolognese, L; Carrera, A; Ducci, K; Falsini, G; Grotti, S; Liistro, F; Limbruno, U; Picchi, A; Pierli, C | 1 |
| Briguori, C; Condorelli, G; Ricciardelli, B; Visconti, G | 1 |
| Cabassi, A; Fiaccadori, E; Gatti, R; Maggiore, U; Orlandini, G; Palmisano, A; Potì, F; Regolisti, G; Ronda, N | 1 |
| Franklin, T; Li, LP; Lu, J; Papadopoulou, MV; Prasad, PV; Solomon, R; Thacker, J; Zhou, Y | 1 |
| Atar, S; Eizenberg, S; Feldman-Idov, Y; Kristal, B; Marzuq, N; Ofir, P; Shema-Didi, L; Sussan, M | 1 |
1 review(s) available for iodixanol and acetylcysteine
| Article | Year |
|---|---|
Renal insufficiency following contrast media administration trial II (REMEDIAL II): RenalGuard system in high-risk patients for contrast-induced acute kidney injury: rationale and design.
Topics: Acetylcysteine; Acute Kidney Injury; Biomarkers; Chi-Square Distribution; Chronic Disease; Contrast Media; Creatinine; Diuretics; Drug Therapy, Combination; Equipment Design; Fluid Therapy; Furosemide; Glomerular Filtration Rate; Humans; Italy; Kidney Diseases; Radiography, Interventional; Renal Insufficiency; Research Design; Risk Assessment; Risk Factors; Sodium Bicarbonate; Time Factors; Treatment Outcome; Triiodobenzoic Acids | 2011 |
8 trial(s) available for iodixanol and acetylcysteine
| Article | Year |
|---|---|
Oral acetylcysteine does not protect renal function from moderate to high doses of intravenous radiographic contrast.
Topics: Acetylcysteine; Acute Kidney Injury; Administration, Oral; Aged; Cardiac Catheterization; Contrast Media; Dose-Response Relationship, Drug; Female; Free Radical Scavengers; Humans; Injections, Intravenous; Kidney Failure, Chronic; Male; Middle Aged; Prospective Studies; Recovery of Function; Triiodobenzoic Acids | 2003 |
A rapid protocol for the prevention of contrast-induced renal dysfunction: the RAPPID study.
Topics: Acetylcysteine; Aged; Cardiac Catheterization; Clinical Protocols; Contrast Media; Creatinine; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Prospective Studies; Rehydration Solutions; Renal Insufficiency; Sodium Chloride; Time Factors; Triiodobenzoic Acids | 2003 |
Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): a randomized comparison of 3 preventive strategies.
Topics: Acetylcysteine; Administration, Oral; Aged; Ascorbic Acid; Cardiovascular Diseases; Contrast Media; Creatinine; Double-Blind Method; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Humans; Infusions, Intravenous; Kidney Diseases; Male; Renal Insufficiency; Risk Factors; Sodium Bicarbonate; Sodium Chloride; Treatment Outcome; Triiodobenzoic Acids | 2007 |
Nephrotoxic effects of iodixanol and iopromide in patients with abnormal renal function receiving N-acetylcysteine and hydration before coronary angiography and intervention: a randomized trial.
Topics: Acetylcysteine; Aged; Angioplasty, Balloon; Contrast Media; Coronary Angiography; Creatinine; Double-Blind Method; Female; Humans; Injections, Intravenous; Iohexol; Kidney; Kidney Diseases; Male; Sodium Chloride; Triiodobenzoic Acids | 2009 |
Is treatment with N-acetylcysteine to prevent contrast-induced nephropathy when using bicarbonate hydration out of date?
Topics: Acetylcysteine; Aged; Contrast Media; Coronary Angiography; Coronary Disease; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Free Radical Scavengers; Glomerular Filtration Rate; Humans; Injections, Intravenous; Iopamidol; Kidney Diseases; Male; Prospective Studies; Sodium Bicarbonate; Treatment Outcome; Triiodobenzoic Acids | 2008 |
The contrast media and nephrotoxicity following coronary revascularization by primary angioplasty for acute myocardial infarction study: design and rationale of the CONTRAST-AMI study.
Topics: Acetylcysteine; Acute Kidney Injury; Angioplasty, Balloon, Coronary; Biomarkers; Contrast Media; Coronary Angiography; Creatinine; Heart Diseases; Humans; Iohexol; Italy; Myocardial Infarction; Prospective Studies; Research Design; Single-Blind Method; Syndrome; Time Factors; Treatment Outcome; Triiodobenzoic Acids | 2010 |
Renal insufficiency following contrast media administration trial II (REMEDIAL II): RenalGuard system in high-risk patients for contrast-induced acute kidney injury: rationale and design.
Topics: Acetylcysteine; Acute Kidney Injury; Biomarkers; Chi-Square Distribution; Chronic Disease; Contrast Media; Creatinine; Diuretics; Drug Therapy, Combination; Equipment Design; Fluid Therapy; Furosemide; Glomerular Filtration Rate; Humans; Italy; Kidney Diseases; Radiography, Interventional; Renal Insufficiency; Research Design; Risk Assessment; Risk Factors; Sodium Bicarbonate; Time Factors; Treatment Outcome; Triiodobenzoic Acids | 2011 |
Prevention of contrast-induced nephropathy with single bolus erythropoietin in patients with diabetic kidney disease: A randomized controlled trial.
Topics: Acetylcysteine; Acute Kidney Injury; Aged; Aged, 80 and over; Biomarkers; Contrast Media; Coronary Angiography; Cystatin C; Cytoprotection; Diabetic Nephropathies; Double-Blind Method; Drug Administration Schedule; Erythropoietin; Female; Humans; Infusions, Intravenous; Iohexol; Israel; Lipocalin-2; Male; Middle Aged; Prospective Studies; Protective Agents; Recombinant Proteins; Renal Insufficiency, Chronic; Risk Factors; Time Factors; Treatment Outcome; Triiodobenzoic Acids | 2016 |
9 other study(ies) available for iodixanol and acetylcysteine
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Protection from contrast-induced nephropathy: is the answer in?
Topics: Acetylcysteine; Acute Kidney Injury; Cardiac Catheterization; Contrast Media; Free Radical Scavengers; Humans; Kidney Failure, Chronic; Triiodobenzoic Acids | 2003 |
Nephrotoxicity of low-osmolality versus iso-osmolality contrast agents: impact of N-acetylcysteine.
Topics: Acetylcysteine; Acute Kidney Injury; Aged; Contrast Media; Female; Fluid Therapy; Humans; Iohexol; Kidney; Male; Middle Aged; Osmolar Concentration; Renal Insufficiency, Chronic; Retrospective Studies; Triiodobenzoic Acids | 2005 |
Prevention of contrast-induced nephropathy in high-risk patients with hemofiltration.
Topics: Acetylcysteine; Confounding Factors, Epidemiologic; Contrast Media; Hemofiltration; Humans; Kidney Diseases; Research Design; Triiodobenzoic Acids; Urine | 2007 |
Letter regarding article by Solomon et al, "Cardiac Angiography in REnally Impaired Patients (CARE) study: a randomized double-blind trial of contrast-induced nephropathy in patients with chronic kidney disease".
Topics: Acetylcysteine; Confounding Factors, Epidemiologic; Contrast Media; Coronary Angiography; Creatinine; Double-Blind Method; Humans; Iopamidol; Kidney Diseases; Randomized Controlled Trials as Topic; Research Design; Sampling Studies; Sodium Bicarbonate; Triiodobenzoic Acids | 2008 |
Incidence of contrast-induced nephropathy in patients with chronic renal insufficiency undergoing multidetector computed tomographic angiography treated with preventive measures.
Topics: Acetylcysteine; Aged; Angiography; Contrast Media; Coronary Angiography; Creatinine; Female; Humans; Kidney Diseases; Kidney Failure, Chronic; Male; Sodium Bicarbonate; Tomography, X-Ray Computed; Triiodobenzoic Acids | 2008 |
N-Acetylcysteine added to volume expansion with sodium bicarbonate does not further prevent contrast-induced nephropathy: results from the cardiac angiography in renally impaired patients study.
Topics: Acetylcysteine; Aged; Buffers; Coronary Angiography; Creatinine; Female; Free Radical Scavengers; Glomerular Filtration Rate; Humans; Iopamidol; Kidney Diseases; Male; Plasma Substitutes; Retrospective Studies; Risk Factors; Sodium Bicarbonate; Triiodobenzoic Acids | 2009 |
Effects of the radiocontrast agent iodixanol on endothelial cell morphology and function.
Topics: Acetylcysteine; Cell Membrane; Cells, Cultured; Chaperonin 60; Contrast Media; Endothelial Cells; Fluorescent Antibody Technique; Fluorobenzenes; Humans; Immunoenzyme Techniques; Microscopy, Confocal; Oxidative Stress; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Triiodobenzoic Acids; Tumor Necrosis Factor-alpha | 2013 |
Efficacy of preventive interventions for iodinated contrast-induced acute kidney injury evaluated by intrarenal oxygenation as an early marker.
Topics: Acetylcysteine; Acute Kidney Injury; Acute-Phase Proteins; Animals; Biomarkers; Contrast Media; Disease Models, Animal; Diuretics; Free Radical Scavengers; Furosemide; Iohexol; Ioxaglic Acid; Kidney; Lipocalin-2; Lipocalins; Magnetic Resonance Imaging; Male; Oxygen; Proto-Oncogene Proteins; Rats; Rats, Sprague-Dawley; Triiodobenzoic Acids | 2014 |